Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Who should be taking antimalarial drugs as treatment against COVID-19?

Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.

2 Apr 2020

COVID-19 by the numbers

Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.

2 Apr 2020

Public health interventions will drive economic recovery from COVID-19

A major new study titled “Pandemics Depress the Economy, Public Health Interventions Do Not: Evidence from the 1918 Flu,” by MIT economist Emil Verner and others, and published as a working paper in the Social Science Research Network, puts the role of public health measures and financial welfare during public health crises into perspective.

2 Apr 2020

Can cats and dogs catch or spread COVID-19?

A recent report from Hong Kong that two dogs had tested positive for the novel coronavirus SARS-CoV-2 had pet owners in a tizzy. This was compounded by news that a cat owned by a COVID-19 patient had developed symptoms of the illness in Belgium – such as breathing trouble and diarrhea – a week after the owner tested positive. The cat’s vomit and feces were subsequently found to be positive for the viral genome.

2 Apr 2020

MIT launches new technique to mass manufacture disposable face shields

The shortage of personal protective equipment (PPE) available to healthcare professionals has become increasingly problematic as Covid-19 cases continue to surge.

2 Apr 2020

COVID-19: What the illness looks like

With increasing information about COVID-19 disease gathered first-hand, a more accurate picture of the clinical features is coming together.

2 Apr 2020

Promising vaccine patch candidate for COVID-19

In a breath of fresh air, scientists from the University of Pittsburgh School of Medicine reported that they had developed a potential new vaccine against the SARS-CoV-2 virus, which is causing the current COVID-19 pandemic. The vaccine has been tested in mice. When administered through a small patch only the size of a fingertip, the vaccine was found to generate protective neutralizing antibodies against the virus, in adequate quantities.

2 Apr 2020

Tulane University adds second avenue for COVID-19 testing

Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.

2 Apr 2020

Patients with hypertension, diabetes and heart disease more likely to die from COVID-19

As the coronavirus disease (COVID-19) evolves, important information emerges, thanks to studies and analyses undertaken by scientists and health experts. With more data available based on patients in actual healthcare settings, scientists have more information on how the virus affects the body and who are at most risk of the disease.

2 Apr 2020

Scientists estimate 2 to 3 percent of Hubei Province’s population has been infected with coronavirus

The coronavirus disease (COVID-19) pandemic has shocked the world. It was first reported in Wuhan City, Hubei Province, in China as a pneumonia-like illness seen in patients who had one thing in common – they visited the Huanan seafood market. Since then, the virus has spread to 180 countries and territories, infecting over 937,000 people worldwide. Now, a new mathematical model developed by scientists at the Universita degli Studi di Napoli Federico II, Italy, shows that about 2 to 3 percent of the total population of Hubei Province has been infected.

2 Apr 2020

How (easily) does the novel coronavirus spread?

Viruses are tiny bundles of DNA or RNA which have the ability to infect host cells, hijack the machinery of the host cell and then replicate. Once the host cell’s resources are exhausted, the viral particles are released to infect other cells. In this way, the viruses ensure their survival, often at the expense of the host.

1 Apr 2020

What are coronaviruses and COVID-19?

The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.

1 Apr 2020

Global nuclear medicine community shares approaches to contain the spread of COVID-19

In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

1 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Measuring the severity of COVID-19 using a model-based analysis

Researchers have modeled the progression and severity of COVID-19. Their study titled “Estimates of the severity of coronavirus disease 2019: a model-based analysis” was published in the latest issue of The Lancet Infectious Diseases.

1 Apr 2020

Healthy Nevada Project participants report on possible exposure and risks of COVID-19

The Healthy Nevada Project, a first-of-its-kind, community-based population health study combining genetic, clinical, environmental and social data, offers free genetic testing to every Nevadan interested in learning more about their health and genetic profile.

1 Apr 2020

Estimating the case fatality ratio for COVID-19

The Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) that causes COVID-19 disease has affected 932,605 individuals and has taken 46,809 lives worldwide. Now, researchers have published a review on the likelihood of survival after SARS-CoV-2 infection. The study titled, “Likelihood of survival of coronavirus disease 2019” is published in the latest issue of The Lancet Infectious Diseases.

1 Apr 2020

NYU researchers capture 3D data on human interactions with COVID-19 infection sources

New York University researchers are in the field capturing highly detailed three-dimensional data on human movements and behaviors -- particularly around medical facilities, public transportation systems, and essential services -- to document the complex landscape of "surface vectors" and thus opportunities for COVID-19 transmission.

1 Apr 2020

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Phoseon’s KeyPro™ family of products uses high-intensity, deep ultraviolet light to disinfect and decontaminate laboratory equipment and surfaces. Independent testing has shown efficacy of KeyPro against viruses, bacteria, fungi, and biomolecules like ribonuclease.

From Phoseon Technology 1 Apr 2020

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

A game-changing point of care coronavirus test from global diagnostics company Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions will launch in April 2020.

From Randox Laboratories Ltd. 1 Apr 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Who should be taking antimalarial drugs as treatment against COVID-19?

COVID-19 by the numbers

Public health interventions will drive economic recovery from COVID-19

Can cats and dogs catch or spread COVID-19?

MIT launches new technique to mass manufacture disposable face shields

COVID-19: What the illness looks like

Promising vaccine patch candidate for COVID-19

Tulane University adds second avenue for COVID-19 testing

Patients with hypertension, diabetes and heart disease more likely to die from COVID-19

Scientists estimate 2 to 3 percent of Hubei Province’s population has been infected with coronavirus

How (easily) does the novel coronavirus spread?

What are coronaviruses and COVID-19?

Global nuclear medicine community shares approaches to contain the spread of COVID-19

Putting an end to the pandemic

Measuring the severity of COVID-19 using a model-based analysis

Healthy Nevada Project participants report on possible exposure and risks of COVID-19

Estimating the case fatality ratio for COVID-19

NYU researchers capture 3D data on human interactions with COVID-19 infection sources

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in